Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Interest & Investment Income (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Interest & Investment Income for 11 consecutive years, with $3.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income fell 18.3% year-over-year to $3.1 million, compared with a TTM value of $10.5 million through Dec 2025, up 3.1%, and an annual FY2025 reading of $10.5 million, up 3.1% over the prior year.
  • Interest & Investment Income was $3.1 million for Q4 2025 at Wave Life Sciences, up from $2.2 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $3.7 million in Q4 2024 and bottomed at $5000.0 in Q4 2021.
  • Average Interest & Investment Income over 5 years is $1.5 million, with a median of $1.9 million recorded in 2023.
  • The sharpest move saw Interest & Investment Income plummeted 98.9% in 2021, then soared 16400.0% in 2022.
  • Year by year, Interest & Investment Income stood at $5000.0 in 2021, then skyrocketed by 16400.0% to $825000.0 in 2022, then soared by 123.52% to $1.8 million in 2023, then surged by 102.71% to $3.7 million in 2024, then dropped by 18.3% to $3.1 million in 2025.
  • Business Quant data shows Interest & Investment Income for WVE at $3.1 million in Q4 2025, $2.2 million in Q3 2025, and $2.4 million in Q2 2025.